CVS Health Corporation (LON:0HRS)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 70.18B |
| Revenue (ttm) | 280.52B |
| Net Income (ttm) | 3.31B |
| Shares Out | n/a |
| EPS (ttm) | 2.62 |
| PE Ratio | 21.22 |
| Forward PE | 11.18 |
| Dividend | 2.04 (2.88%) |
| Ex-Dividend Date | Jul 22, 2025 |
| Volume | 4,472 |
| Average Volume | 5,961 |
| Open | 74.42 |
| Previous Close | 74.60 |
| Day's Range | 74.42 - 75.54 |
| 52-Week Range | 43.56 - 75.54 |
| Beta | 0.62 |
| RSI | 69.46 |
| Earnings Date | Oct 29, 2025 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
CVS Health to pay more than $12M to settle drug pricing allegations in Massachusetts
CVS Health (CVS) stock is in focus as the company inks a $12.25M deal to settle claims that it overcharged for drugs supplied to Massachusetts Medicaid. Read more here.
CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
Jim Cramer talks what is driving CVS higher this year
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
Jim Cramer talks what is driving CVS higher this year
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
Jim Cramer says CVS stock is a buy at these levels. Here's why
CNBC's Jim Cramer said he's optimistic about CVS and explained to investors why he the healthcare company's stock is worth buying
The Big 3: LLY, BA, CVS
Dan Deming considers Friday's trading action after Jerome Powell's Jackson Hole speech "remarkable." On stocks he's watching ahead, he expects Eli Lilly (LLY) to rebound off a significant sell-off, Bo...
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now.
Only 2 Weeks Away – Register Now! Florida C-suite executives invited to HMG Strategy's 5th Annual C-Level Technology Leadership Summit on September 4
FAIRFIELD, Conn., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Save the date! C-level executives from the Sunshine State who want to find out how technology helps them reimagine their enterprise and reshape thei...
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
CVS Health Inc. (NYSE: CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ: GILD) new HIV prevention drug Yeztugo to its commercial plans . In June, the U.S. Food and Drug Administration (FDA) ...
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
CVS Health Inc. CVS said it will not add Gilead Sciences Inc.'s GILD new HIV prevention drug Yeztugo to its commercial plans.
CVS Health reportedly excludes coverage for Gilead’s new HIV drug for now
Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medic...
CVS Health ends in red after six-session rally
CVS unit ordered to pay $290M for overcharging Medicare drugs
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules
CVS Health is not entitled to coverage from insurers, including AIG and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday.
CVS shares are breaking out to the upside after a 3-year bear market cycle, according to the charts
Chart strategist Katie Stockton breaks down the technical backdrop in CVS.
CVS upgraded at UBS on valuation, growth prospects
UBS upgrades CVS to buy rating, sees further recovery ahead
UBS analyst Kevin Caliendo's revised price target implies 15% upside ahead for shares of the health care benefit and pharmacy chain.
CVS Health: Outlier In Healthcare Implosion - Further Margin Recovery Ahead
This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Duolingo, Netflix, Target, CVS, Sunrun, Live Nation & more
Here are the biggest calls on Wall Street on Monday.
CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?
Costco has dropped the so-called abortion pill nationwide, but it still sells Plan B, a form of contraception.